Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.06.2022 | Case report

Fluticasone-propionate

Sjogren's-syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Zdziarski P, et al. Microbiome Analysis and Pharmacovigilance After Inhaled Glucocorticoid: Oral Dysbiosis With the Isolation of Three Rothia Species and Subsequent Sjogren's Syndrome. Frontiers in Pharmacology 13: Apr 2022. Available from: URL: http://www.frontiersin.org/Pharmacology Zdziarski P, et al. Microbiome Analysis and Pharmacovigilance After Inhaled Glucocorticoid: Oral Dysbiosis With the Isolation of Three Rothia Species and Subsequent Sjogren's Syndrome. Frontiers in Pharmacology 13: Apr 2022. Available from: URL: http://​www.​frontiersin.​org/​Pharmacology
Metadaten
Titel
Fluticasone-propionate
Sjogren's-syndrome: case report
Publikationsdatum
01.06.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-17060-z

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Prednisolone

Case report

Antineoplastic

Case report

Hyaluronic-acid